Abiopharma

🔍 FINNEY ELISHA W (Executive)

Company: Viatris Inc (VTRS)

Report Date: 2026-03-06

Detailed Transactions and Holdings:

• Acquired 23,660 shares of Common Stock (Direct)
  Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 61,492.00 | transaction_form_type: 4
• Acquired 1,175 shares of Common Stock (Direct)
  Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 62,667.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 23,660 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2
• Sold 1,174 shares of Dividend Equivalent Units (Derivative)
  Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F3
• Acquired 15,890 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 15,890.00 | transaction_form_type: 4 | Footnotes: F4, F4

Footnotes:

• F1: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
• F2: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026.
• F3: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.
• F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027.